Derek Dostal

Davis Polk advised the sole sales agent in connection with an SEC-registered at-the-market offering by Tellurian Inc. of its shares of common stock having an aggregate offering price of up…

Davis Polk advised the joint bookrunners and representatives of the several underwriters in connection with an SEC-registered offering of $450 million aggregate principal amount of a new…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Silicon Laboratories Inc. of $400 million aggregate principal amount of its…

Davis Polk advised IHS Markit Ltd. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 4.75% senior notes due 2025. IHS Markit intends…

Davis Polk advised REV Group, Inc. on its $275 million initial public offering of 12,500,000 shares of common stock. The shares of common stock are listed on the New York Stock Exchange…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Tech Data Corporation of $500 million aggregate principal amount of its 3.700% senior…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $345 million aggregate principal amount of Veeco’s 2.70% convertible senior notes due 2023, which…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Xylem Inc. of $500 million aggregate principal amount of its 3.250% senior notes due…

Davis Polk advised AC Immune SA in connection with its $75.9 million U.S. initial public offering. AC Immune sold 6,900,000 of its common shares in the offering, which included 900,000…

Davis Polk advised the representative of the initial purchasers in connection with a Regulation S/Rule 144A offering of $400 million aggregate principal amount of PDC Energy, Inc.’s 6.125%…